← Back to Search

Retrospective for Peripheral Arterial Disease (PROWL Trial)

N/A
Recruiting
Led By Sean Lyden, MD
Research Sponsored by SurModics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up peri-procedural (by the end of the index procedure)
Awards & highlights

PROWL Trial Summary

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

Eligible Conditions
  • Peripheral Arterial Disease
  • Acute Limb Ischemia

PROWL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~peri-procedural (by the end of the index procedure)
This trial's timeline: 3 weeks for screening, Varies for treatment, and peri-procedural (by the end of the index procedure) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of device related Major Adverse Events (MAEs)
Procedural Success
Secondary outcome measures
Adjunctive procedures
Ankle Brachial Index (ABI)
Characterize subject index procedure hospitalization course at discharge
+15 more

PROWL Trial Design

1Treatment groups
Experimental Treatment
Group I: RetrospectiveExperimental Treatment1 Intervention
All subjects in whom the Pounce Thrombectomy System was attempted will be included.

Find a Location

Who is running the clinical trial?

SurModics, Inc.Lead Sponsor
6 Previous Clinical Trials
577 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
494 Patients Enrolled for Peripheral Arterial Disease
Sean Lyden, MDPrincipal InvestigatorThe Cleveland Clinic
8 Previous Clinical Trials
2,403 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
820 Patients Enrolled for Peripheral Arterial Disease
Joseph Campbell, MDPrincipal InvestigatorOhioHealth
1 Previous Clinical Trials
46 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
46 Patients Enrolled for Peripheral Arterial Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~260 spots leftby May 2025